V-Yes-1 Yamaguchi Sarcoma Viral Related Oncogene Homolog (LYN) (N-Term) Peptide
LYN
Reactivité: Humain
Hôte: Synthetic
BP, WB
N° du produit ABIN979668
Aperçu rapide pour V-Yes-1 Yamaguchi Sarcoma Viral Related Oncogene Homolog (LYN) (N-Term) Peptide (ABIN979668)
Antigène
LYN
(V-Yes-1 Yamaguchi Sarcoma Viral Related Oncogene Homolog (LYN))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- N-Term
-
Séquence
- DPTSNKQQRP VPESQLLPGQ RFQTKDPEEQ GDIVVALYPY DGIHPDDLSF
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-LYN Antibody(ARP54696_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
V-Yes-1 Yamaguchi Sarcoma Viral Related Oncogene Homolog (LYN) peptide
LYN Reactivité: Humain, Boeuf (Vache) Hôte: Synthetic BP, Imm
-
-
Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- LYN (V-Yes-1 Yamaguchi Sarcoma Viral Related Oncogene Homolog (LYN))
-
Sujet
-
LYN down regulates expression of stem cell growth factor receptor (KIT).LYN acts as an effector of EpoR (erythropoietin receptor) in controlling KIT expression and may play a central role in erythroid differentiation during the switch between proliferation and maturation.LYN acts as a positive regulator of cell movement while negatively regulating adhesion to stromal cells by inhibiting the ICAM-1-binding activity of beta-2 integrins. LYN acts as the mediator that relays suppressing signals from the chemokine receptor CXCR4 to beta-2 integrin LFA-1 in hematopoietic precursors. Involved in induction of stress-activated protein kinase (SAPK), but not ERK or p38 MAPK, in response to genotoxic agents.LYN induces SAPK by a MKK7- and MEKK1-dependent mechanism. The LYN -> MEKK1 -> MKK7 -> SAPK pathway is functional in the induction of apoptosis by genotoxic agents.
Alias Symbols: FLJ26625, JTK8, p53Lyn, p56Lyn
Protein Interaction Partner: KIT,HCVgp1,KIT,LYN,PDE4D,RGS16,UBB,ACTB,ADAM15,BANK1,BCAR1,BTK,CASP3,CASP7,CASP9,CBL,CBLC,CD19,CD22,CD24,CD36,CD79A,CD79B,CDK1,CDK2,CDKN1B,CHST15,CRKL,CSF1R,CSF2RA,CSF2RB,CSF3R,CSK,CSNK2B,CTLA4,DAPP1,DLG4,DOK1,DOK2,DOK3,EGFR,EPOR,EVL,FCAR,FCER1G,FCGR2A,FC
Protein Size: 512 -
Poids moléculaire
- 58 kDa
-
ID gène
- 4067
-
NCBI Accession
- NM_002350, NP_002341
-
UniProt
- P07948
Antigène
-
Vous êtes ici:
